Miniature cardiopulmonary bypass--the Hammersmith experience.
The decision to embark on a miniature cardiopulmonary bypass programme requires careful planning. The objective of this paper is to present our experience and initial findings for consideration by our multidisciplinary peers, who may wish to implement this technology at their own hospitals. The paper reviews the evolution of our programme over the first 150 clinical cases and our current position on the advantages and disadvantages of miniature cardiopulmonary bypass.
Mulholland
J W
JW
Department of Clinical Perfusion Science, Hammersmith Hospital, London, UK. john@londonperfusionscience.com
Anderson
J R
JR
Yarham
G J
GJ
Tuladhur
S
S
Saed
I
I
Oliver
M D
MD
D000925:Anticoagulants / Q000008:administration & dosage*; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D001793:Blood Preservation / Q000379:methods*; D002315:Cardiopulmonary Bypass / Q000379:methods*; D047549:Coronary Artery Bypass, Off-Pump / Q000379:methods*; D004502:Education, Medical, Continuing; D005112:Extracorporeal Circulation / Q000379:methods; D013502:General Surgery / Q000193:education; D006493:Heparin / Q000008:administration & dosage*; D006801:Humans; D019060:Minimally Invasive Surgical Procedures / Q000379:methods; D011182:Postoperative Care; D011300:Preoperative Care; D013503:Surgery Department, Hospital; D006113:United Kingdom
D000925:Anticoagulants; D006493:Heparin